CoChat

Protective Effect of Probiotic Bacteria and Estrogen in Preventing HIV-1-Mediated Impairment of Epithelial Barrier Integrity in Female Genital Tract

Open access

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Abstract

Approximately 40% of global HIV-1 transmission occurs in the female genital tract (FGT) through heterosexual transmission. Epithelial cells lining the FGT provide the first barrier to HIV-1 entry. Previous studies have suggested that certain hormonal contraceptives or a dysbiosis of the vaginal microbiota can enhance HIV-1 acquisition in the FGT. We examined the effects of lactobacilli and female sex hormones on the barrier functions and innate immune responses of primary endometrial genital epithelial cells (GECs). Two probiotic strains, Lactobacillus reuteri RC-14 and L. rhamnosus GR-1, were tested, as were sex hormones estrogen (E2), progesterone (P4), and the hormonal contraceptive medroxyprogesterone acetate (MPA). Our results demonstrate that probiotic lactobacilli enhance barrier function without affecting cytokines. Treatment of GECs with MPA resulted in reduced barrier function. In contrast, E2 treatment enhanced barrier function and reduced production of proinflammatory cytokines. Comparison of hormones plus lactobacilli as a pre-treatment prior to HIV exposure revealed a dominant effect of lactobacilli in preventing loss of barrier function by GECs. In summary, the combination of E2 and lactobacilli had the best protective effect against HIV-1 seen by enhancement of barrier function and reduction in proinflammatory cytokines. These studies provide insights into how probiotic lactobacilli in the female genital microenvironment can alter HIV-1-mediated barrier disruption and how the combination of E2 and lactobacilli may decrease susceptibility to primary HIV infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells8101120

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Exposure to probiotic strains of lactobacilli improves barrier function of primary genital epithelial cells and does not alter viability or production of pro-inflammatory cytokines and chemokines. Confluent monolayers of GECs were treated for 2 h with probiotic strains L. rhamnosus GR-1 and L. reuteri RC-14 abbreviated GR-1 and RC-14 respectively and/or no bacteria (Ctrl). After treatment, non-adherent lactobacilli were removed, and GECs were monitored for a further 24 h. (A) TER was measured pre-treatment and at 24 h post-treatment with lactobacilli. TER is expressed as percent of pre-treatment TER. (B) Following treatment with bacteria, primary GECs were incubated with FITC-dextran dye on the apical surface, and FITC-dextran leakage in the basolateral compartment was measured after 24 h. Data are expressed as a percentage of FITC-dextran added to the apical compartment. (C) LDH release (Abs490) by GECs 24 h after treatment with GR-1, RC-14 or no bacteria, or from GEC cultures lysed to release total LDH (positive control). (D–G) 24 h post-treatment with lactobacilli, cell supernatants were collected and analyzed for the presence of TNF-α, IL-1α, IL-8, and RANTES. Dashed line indicates assay limit of detection. Data shown are representative of 6–9 separate experiments done on tissues taken from 6-9 different donors and shown as mean ± SEM. Each experiment had 3 replicate cultures for each experimental condition. Statistical significance is indicated as: **** p < 0.0001, *** p < 0.001, ** p < 0.01.
Figure 1 Exposure to probiotic strains of lactobacilli improves barrier function of primary genital epithelial cells and does not alter viability or production of pro-inflammatory cytokines and chemokines. Confluent monolayers of GECs were treated for 2 h with probiotic strains L. rhamnosus GR-1 and L. reuteri RC-14 abbreviated GR-1 and RC-14 respectively and/or no bacteria (Ctrl). After treatment, non-adherent lactobacilli were removed, and GECs were monitored for a further 24 h. (A) TER was measured pre-treatment and at 24 h post-treatment with lactobacilli. TER is expressed as percent of pre-treatment TER. (B) Following treatment with bacteria, primary GECs were incubated with FITC-dextran dye on the apical surface, and FITC-dextran leakage in the basolateral compartment was measured after 24 h. Data are expressed as a percentage of FITC-dextran added to the apical compartment. (C) LDH release (Abs490) by GECs 24 h after treatment with GR-1, RC-14 or no bacteria, or from GEC cultures lysed to release total LDH (positive control). (D–G) 24 h post-treatment with lactobacilli, cell supernatants were collected and analyzed for the presence of TNF-α, IL-1α, IL-8, and RANTES. Dashed line indicates assay limit of detection. Data shown are representative of 6–9 separate experiments done on tissues taken from 6-9 different donors and shown as mean ± SEM. Each experiment had 3 replicate cultures for each experimental condition. Statistical significance is indicated as: **** p < 0.0001, *** p < 0.001, ** p < 0.01.CC BY · PubMed Central
Figure 2 Estrogen treatment reduces barrier leakage and decreases pro-inflammatory cytokine response in primary genital epithelial cells. Primary GECs were grown in the absence (NH = no hormone) or presence of sex hormones E2, P4 or MPA until confluent. (A) TER was measured every alternate day starting day 3 post-seeding of cells. (B) Following hormone treatment in confluent GEC monolayers, cells were incubated for 24 h with FITC-dextran dye applied to the apical side. 24 h later, 50 µL of basolateral supernatant was collected and FITC-dextran dye was measured using a microplate reader. Dextran leakage was expressed as a percentage of FITC-dextran added to the apical compartment. (C) Supernatants taken from confluent monolayers grown in presence of hormone and contraceptive were assessed for LDH release to determine cell stress and cytotoxicity. (D–G) Supernatants from GECs grown in the presence of E2, P4 or MPA were collected and analyzed for the presence of TNF-α, IL-1α, IL-8, and RANTES. Dashed line indicates lowest detection limit of individual cytokine and chemokine in an assay. Data shown is representative of 6–9 separate experiments done on 6–9 different tissues taken from different donors and shown as mean ± SEM. Each experiment had 3 replicate cultures for each experimental condition. Statistical significance is indicated: **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.
Figure 2 Estrogen treatment reduces barrier leakage and decreases pro-inflammatory cytokine response in primary genital epithelial cells. Primary GECs were grown in the absence (NH = no hormone) or presence of sex hormones E2, P4 or MPA until confluent. (A) TER was measured every alternate day starting day 3 post-seeding of cells. (B) Following hormone treatment in confluent GEC monolayers, cells were incubated for 24 h with FITC-dextran dye applied to the apical side. 24 h later, 50 µL of basolateral supernatant was collected and FITC-dextran dye was measured using a microplate reader. Dextran leakage was expressed as a percentage of FITC-dextran added to the apical compartment. (C) Supernatants taken from confluent monolayers grown in presence of hormone and contraceptive were assessed for LDH release to determine cell stress and cytotoxicity. (D–G) Supernatants from GECs grown in the presence of E2, P4 or MPA were collected and analyzed for the presence of TNF-α, IL-1α, IL-8, and RANTES. Dashed line indicates lowest detection limit of individual cytokine and chemokine in an assay. Data shown is representative of 6–9 separate experiments done on 6–9 different tissues taken from different donors and shown as mean ± SEM. Each experiment had 3 replicate cultures for each experimental condition. Statistical significance is indicated: **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.CC BY · PubMed Central
Figure 3 Probiotic strains of lactobacilli ameliorate HIV-1-mediated barrier disruption and downregulate proinflammatory cytokine production by GECs. GECs were treated for 2 h with probiotic strains L. rhamnosus GR-1 and L. reuteri RC-14 abbreviated GR-1 and RC-14 respectively or no bacteria (Control). Following treatment, various cultures of GECs were then exposed to HIV-1 or no virus (Mock) and monitored for 24 h. (A,B) TER values were observed pre- and 24 h post-HIV-1 exposure. TER is expressed as percent of TER measured before HIV-1 exposure. (C,D) Following treatment with lactobacilli and during viral exposure, GEC cultures were treated apically with FITC-labeled dextran dye. At 24 h, 50 µL of basolateral were collected and fluorescence was measured using a microplate reader. The dextran leakage in the basolateral compartment is expressed as a percentage of dextran added to the apical compartment. (E–H) 24 h post-exposure to HIV-1, cell supernatants were collected and analyzed for TNF-α, IL-1α, IL-8, and RANTES. Dashed line indicates assay limit of detection. Data shown is representative of 6–9 separate experiments done on cells isolated from 6–9 different tissues, each experiment had 3 replicate cultures for each experimental condition. Data is plotted as mean + SEM. Statistical significance is indicated: **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.
Figure 3 Probiotic strains of lactobacilli ameliorate HIV-1-mediated barrier disruption and downregulate proinflammatory cytokine production by GECs. GECs were treated for 2 h with probiotic strains L. rhamnosus GR-1 and L. reuteri RC-14 abbreviated GR-1 and RC-14 respectively or no bacteria (Control). Following treatment, various cultures of GECs were then exposed to HIV-1 or no virus (Mock) and monitored for 24 h. (A,B) TER values were observed pre- and 24 h post-HIV-1 exposure. TER is expressed as percent of TER measured before HIV-1 exposure. (C,D) Following treatment with lactobacilli and during viral exposure, GEC cultures were treated apically with FITC-labeled dextran dye. At 24 h, 50 µL of basolateral were collected and fluorescence was measured using a microplate reader. The dextran leakage in the basolateral compartment is expressed as a percentage of dextran added to the apical compartment. (E–H) 24 h post-exposure to HIV-1, cell supernatants were collected and analyzed for TNF-α, IL-1α, IL-8, and RANTES. Dashed line indicates assay limit of detection. Data shown is representative of 6–9 separate experiments done on cells isolated from 6–9 different tissues, each experiment had 3 replicate cultures for each experimental condition. Data is plotted as mean + SEM. Statistical significance is indicated: **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.CC BY · PubMed Central
Figure 4 Estrogen treatment prevents HIV-1-mediated barrier disruption in GECs. GECs were grown in the absence (NH) or presence of sex hormones E2, P4 or MPA until confluence was reached. GECs were then exposed to HIV-1 and monitored for 24 h. (A) TER values were observed at 0 h and 24 h after HIV-1 exposure and expressed as percent of pre-treatment TER. Data is derived from 3 separate GEC culture experiments, with a minimum of two replicates per experimental condition were included. (B) FITC-dextran leakage to basolateral compartment after 24 h exposure to HIV-1. The FITC-dextran leakage is expressed as a percentage of FITC-dextran added initially. (C–F) 24 h post HIV-1 exposure, cell supernatants were collected and analyzed for TNF-α, IL-1α, IL-8 and RANTES. Dashed line indicates assay limit of detection. Representative data is shown from 5–8 separate experiments done on cells isolated from 5–8 different tissues obtained from different donors; each experiment had 3 replicate cultures for each experimental condition. Data is plotted as mean + SEM. Statistical significance is indicated: **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.
Figure 4 Estrogen treatment prevents HIV-1-mediated barrier disruption in GECs. GECs were grown in the absence (NH) or presence of sex hormones E2, P4 or MPA until confluence was reached. GECs were then exposed to HIV-1 and monitored for 24 h. (A) TER values were observed at 0 h and 24 h after HIV-1 exposure and expressed as percent of pre-treatment TER. Data is derived from 3 separate GEC culture experiments, with a minimum of two replicates per experimental condition were included. (B) FITC-dextran leakage to basolateral compartment after 24 h exposure to HIV-1. The FITC-dextran leakage is expressed as a percentage of FITC-dextran added initially. (C–F) 24 h post HIV-1 exposure, cell supernatants were collected and analyzed for TNF-α, IL-1α, IL-8 and RANTES. Dashed line indicates assay limit of detection. Representative data is shown from 5–8 separate experiments done on cells isolated from 5–8 different tissues obtained from different donors; each experiment had 3 replicate cultures for each experimental condition. Data is plotted as mean + SEM. Statistical significance is indicated: **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.CC BY · PubMed Central
Figure 5 Probiotic lactobacilli and estrogen ameliorate HIV-1-mediated barrier disruption. GECs were grown in the absence of hormone (NH) or with E2, P4 or MPA until confluence was reached. Primary GEC cultures were treated for 2 h with L. reuteri RC-14 or medium control (Mock). After lactobacilli treatment GECs were exposed to HIV-1 and monitored for 24 h. (A) TER values were observed at 0 and 24 h post-viral exposure and expressed as percent of pre-treatment TER. (B) During viral exposure, primary GECs were incubated with an apical treatment of FITC-dextran dye for 24 h. The FITC-dextran leakage into the basolateral compartment is expressed as a percentage of total FITC-dextran added to the apical compartment. (C–F) 24 h following HIV-1 exposure, cell supernatants were collected and analyzed for TNF-α, IL-1α, IL-8, and RANTES production. Dashed line indicates assay limit of detection. Data are representative of 5–8 experiments from 5–8 different tissues, each tissue obtained from a separate donor. Each experiment had 3 replicate cultures for each experimental condition. Data is plotted as mean + SEM. Statistical significance is indicated: **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.
Figure 5 Probiotic lactobacilli and estrogen ameliorate HIV-1-mediated barrier disruption. GECs were grown in the absence of hormone (NH) or with E2, P4 or MPA until confluence was reached. Primary GEC cultures were treated for 2 h with L. reuteri RC-14 or medium control (Mock). After lactobacilli treatment GECs were exposed to HIV-1 and monitored for 24 h. (A) TER values were observed at 0 and 24 h post-viral exposure and expressed as percent of pre-treatment TER. (B) During viral exposure, primary GECs were incubated with an apical treatment of FITC-dextran dye for 24 h. The FITC-dextran leakage into the basolateral compartment is expressed as a percentage of total FITC-dextran added to the apical compartment. (C–F) 24 h following HIV-1 exposure, cell supernatants were collected and analyzed for TNF-α, IL-1α, IL-8, and RANTES production. Dashed line indicates assay limit of detection. Data are representative of 5–8 experiments from 5–8 different tissues, each tissue obtained from a separate donor. Each experiment had 3 replicate cultures for each experimental condition. Data is plotted as mean + SEM. Statistical significance is indicated: **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.CC BY · PubMed Central
Figure 6 Probiotic lactobacilli and estrogen protect GECs from HIV-1-mediated tight junction degradation. GECs were grown in the presence or absence (NH) of E2, P4 or MPA until confluence was reached. Confluent GECs were pre-treated for 2 h with L. reuteri (RC-14) at 100 CFU/cell or no bacteria. After pre-treatment, non-adherent lactobacilli were removed, and primary GEC were exposed to HIV-1. After 24 h, cells were fixed and stained for ZO-1 tight junction proteins. Images were captured with Olympus confocal microscope. Representative images (×1260 magnification) of each culture condition are shown (A). Fluorescence of 3 different images taken for each culture condition (see Methods for details) and were measured by Image J software (B). Data is plotted as mean + SEM of relative fluorescence. Statistical significance is indicated: **** p < 0.0001, *** p < 0.001, ** p < 0.01.
Figure 6 Probiotic lactobacilli and estrogen protect GECs from HIV-1-mediated tight junction degradation. GECs were grown in the presence or absence (NH) of E2, P4 or MPA until confluence was reached. Confluent GECs were pre-treated for 2 h with L. reuteri (RC-14) at 100 CFU/cell or no bacteria. After pre-treatment, non-adherent lactobacilli were removed, and primary GEC were exposed to HIV-1. After 24 h, cells were fixed and stained for ZO-1 tight junction proteins. Images were captured with Olympus confocal microscope. Representative images (×1260 magnification) of each culture condition are shown (A). Fluorescence of 3 different images taken for each culture condition (see Methods for details) and were measured by Image J software (B). Data is plotted as mean + SEM of relative fluorescence. Statistical significance is indicated: **** p < 0.0001, *** p < 0.001, ** p < 0.01.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 30

Metadata

Authors
Dizzell, S., Nazli, A., Reid, G., & Kaushic, C.
Affiliations
  • McMaster University (CA)
  • Western University (CA)
Corresponding author
Kaushic, Charu
Venue
Cells
Publisher
MDPI AG
Published
2019-09-21
Volume
8
Issue
10
Pages
1120
ISSN
2073-4409 (ISSN-L)
OpenAlex
W2973607368
Cited by
30
References
54
Citations by year
2026: 2 · 2025: 7 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 5 · 2020: 2
FWCI
2.39
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Scholarship@Western (Western University) (submittedVersion, cc-by)
  • Scholarship@Western (Western University) (submittedVersion)
Funders
  • Canadian Institutes of Health Research (FRN 126019, FRN 138657)
  • Ontario HIV Treatment Network (AHRC 779)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
HIV-1, female reproductive tract, epithelial barrier integrity, probiotic lactobacilli, Lactobacillus reuteri RC-14, Lactobacillus rhamnosus GR-1, estrogen, medroxyprogesterone acetate, progesterone, hormonal contraception, inflammatory cytokines, vaginal microbiota, heterosexual transmission, innate immunity
MeSH terms
Adult, Antibiosis, Cell Membrane Permeability, Cells, Cultured, Epithelial Cells, Estradiol, Female, Genitalia, Female, Humans, Immunity, Innate, Lactobacillus, Middle Aged, Progesterone, HIV-1, HIV Infections, Cytoprotection, Probiotics, Primary Cell Culture

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.